![Robert Winn holds forth on big data, bench-to-community research—and being the only African American director of an NCI-designated cancer center](https://cdn.cancerletter.com/media/2020/01/20094725/Winn_4x3.jpg)
![Robert Winn holds forth on big data, bench-to-community research—and being the only African American director of an NCI-designated cancer center](https://cdn.cancerletter.com/media/2020/01/20094725/Winn_4x3.jpg)
Cover Story
Conversation with The Cancer LetterFree
Consider these data points on cancer disparities:
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
Drugs & Targets
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
NCI Trials
![NCI Trials](https://cdn.cancerletter.com/media/2019/05/03161630/CTEP.jpg)
![NCI Trials](https://cdn.cancerletter.com/media/2019/05/03161630/CTEP.jpg)
NCI Trials for Jan. 2020
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
Trending Stories
- Solving problems doctors can’t fix: How Georgetown’s medical-legal partnership saves lives by including lawyers on cancer care teams
Why every cancer center needs a Cancer LAW Project - Before the Olympics were smoke-free, tobacco brand deals ran rampant
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- ACS is using an AI-powered platform in the largest-ever population study of Black women
Time and resources freed up from data management will go to outreach and access - Georgetown-MedStar: Patients with cancer can rely on our lawyers to fight legal issues that harm health
- How a Georgetown med school student found her calling in surgery, law, and health equity